Patent · US Active

Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof

US8492385B2 · kind B2 · utility

6Cited by

0References

9Claims

0Family size

Assignee

Wilex AG · DE

Inventors

Alfons Grunenberg · Wuppertal, DE
Jana Lenz · Wuppertal, DE

Key dates

Filing date	Mar 29, 2010
Grant date	Jul 23, 2013
Priority date	—
Expiry date	Jul 18, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D295/185
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel crystalline modifications of N-α-(2,4,6-triisopropylphenyl-sulfonyl)-3-hydroxyamidino-(L)-phenylalanine 4-ethoxy-carbonylpiperazide and/or salts thereof, which can be used as pharmaceutical agents, and to pharmaceutical compositions and pharmaceutical uses comprising these novel crystalline modifications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.